Diisopropylethylamine → HCID 25099515, compound
Reaction equation
[F:1][C:2]1[CH:3]=[C:4]([C:8]2[N:13]=[C:12]([CH3:14])[C:11]([C:15]([OH:17])=O)=[CH:10][N:9]=2)[CH:5]=[CH:6][CH:7]=1.CN(C(ON1N=NC2C=CC(=CC1=2)Cl)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.CCN(C(C)C)C(C)C.[F:52][C:53]1[CH:54]=[C:55]2[C:59](=[CH:60][CH:61]=1)[N:58]([NH2:62])[CH:57]=[C:56]2[CH3:63]>CN(C=O)C.O.CCOC(C)=O>[F:52][C:53]1[CH:54]=[C:55]2[C:59](=[CH:60][CH:61]=1)[N:58]([NH:62][C:15]([C:11]1[C:12]([CH3:14])=[N:13][C:8]([C:4]3[CH:5]=[CH:6][CH:7]=[C:2]([F:1])[CH:3]=3)=[N:9][CH:10]=1)=[O:17])[CH:57]=[C:56]2[CH3:63]Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 3
Procedure
A solution of 2-(3-fluoro-phenyl)-4-methyl-pyrimidine-5-carboxylic acid (645 mg, 2.78 mmol), HCTU (1.25 g, 3.02 mmol), and DIPEA (1.35 mL, 7.73 mmol) in DMF (15 mL) is stirred at rt under N2 for 10 min. 5-Fluoro-3-methyl-indol-1-ylamine (380 mg, 2.31 mmol) is added. The resulting mixture is stirred at rt overnight. The mixture is portioned between EtOAc and water. The organic phase is separated, washed with saturated aqueous NaHCO3, water and brine, dried (MgSO4), filtered and concentrated in vacuo. The residue is triturated in ether to afford 2-(3-fluoro-phenyl)-4-methyl-pyrimidine-5-carboxylic acid (5-fluoro-3-methyl-indol-1-yl)-amide (533 mg, 61%) as a solid. MS: 379 (M+H). 1H NMR (300 MHz, DMSO-d6): δ 11.84 (s, 1H), 9.21 (s, 1H), 8.32 (d, 1H), 8.17-8.15 (m, 1H), 7.66-7.61 (m, 1H), 7.47-41 (m, 2H), 7.36-7.34 (m, 2H), 7.05 (dt, 1H), 2.76 (s, 3H), 2.26 (s, 3H). IC50=6 nM.
Workup
- customThe organic phase is separated
- washwashed with saturated aqueous NaHCO3, water and brine
- dry with materialdried (MgSO4)
- filtrationfiltered
- concentrationconcentrated in vacuo
- customThe residue is triturated in ether
Sources & evidence
- ORD record
- ord-4fcf6307cd59437090c0ed64cc0ca6e0
- Source dataset
- uspto-grants-2012_09
- Patent number
- US08258130B2
Reaction notes
Loading…